Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within In Vitro Diagnostics therapeutic area.
Point of Care (POC) analyzers are small-size, handheld, or bench-top analyzers.
Point of Care Testing (POC) is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care. POC is typically performed by non-laboratory personnel and the results are used for clinical decision making.
POC has a range of complexity and procedures that vary from manual methodologies to automated analyzers. POC devices are often ‘handheld’ or may be small portable analyzers. POC analyzers are small-scale analyzers, often used in small laboratories and physician labs, where the workload and daily sample inflow are less. They often use disposable test cartridges and can provide faster results.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Point of Care (POC) Analyzers and evolving competitive landscape:
– Insightful review of the key industry trends.
– Annualized total Point of Care (POC) Analyzers market revenue by segment and market outlooks from 2015-2036.
– Market level data on units, average selling prices and market values.
Global, Regional and Country level market specific insights:
– Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
– SWOT analysis for Point of Care (POC) Analyzers market.
– Competitive dynamics insights and trends provided for Point of Care (POC) Analyzers market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
– Country specific overview of the healthcare system.
– Country specific reimbursement policies.
– Country specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Sysmex Corp, Roche Diagnostics International Ltd, Abbott Laboratories, Cepheid Inc + Radiometer Medical ApS, Horiba Ltd, Siemens Healthineers AG, Hologic Inc, EKF Diagnostics Holdings Plc, Quidel Corp, DiaSorin Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
– CMO executives who must have deep understanding of the Point of Care (POC) Analyzers market place to make strategic planning and investment decisions.
– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Key Highlights
Reasons to Buy
The model will enable you to:
– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
– Develop business strategies by understanding the trends shaping and driving Point of Care (POC) Analyzers market.
– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Point of Care (POC) Analyzers market in the future.
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
– Track device sales in the global and country-specific Point of Care (POC) Analyzers market from 2015-2036.
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Roche Diagnostics International Ltd
Abbott Laboratories
Cepheid Inc + Radiometer Medical ApS
Horiba Ltd
Siemens Healthineers AG
Hologic Inc
EKF Diagnostics Holdings Plc
Quidel Corp
DiaSorin Inc
Others
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more In Vitro Diagnostics reports